Biosimilars: Are They Bioequivalent?

Publisher： Karger

E-ISSN： 1421-9875|32|1|82-87

ISSN： 0257-2753

Source： Digestive Diseases, Vol.32, Iss.1, 2014-12, pp. : 82-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-TNFs: Originators and Biosimilars

By  

Digestive Diseases, Vol. 34, Iss. 1-2, 2016-03 ,pp. : 132-139

Karger

Access to resources Recommend Favorite

Biosimilars: Aktueller Stand der Serienreife

By Aringer M.   Dörner T.  

Zeitschrift für Rheumatologie, Vol. 72, Iss. 9, 2013-11 ,pp. : 873-877

Springer Publishing Company

Access to resources Recommend Favorite

Combining Therapeutic Drug Monitoring with Biosimilars, a Strategy to Improve the Efficacy of Biologicals for Treating Inflammatory Bowel Diseases at an Affordable Cost

By  

Digestive Diseases, Vol. 35, Iss. 1-2, 2017-02 ,pp. : 61-68

Karger

Access to resources Recommend Favorite

Does the Introduction of Biosimilars Change Our Understanding about Treatment Modalities for Inflammatory Bowel Disease?

By  

Digestive Diseases, Vol. 35, Iss. 1-2, 2017-02 ,pp. : 74-82

Karger

Access to resources Recommend Favorite